[go: up one dir, main page]

NO994520D0 - Sinkfrie insulinkrystaller for anvendelse i pulmonale preparater - Google Patents

Sinkfrie insulinkrystaller for anvendelse i pulmonale preparater

Info

Publication number
NO994520D0
NO994520D0 NO994520A NO994520A NO994520D0 NO 994520 D0 NO994520 D0 NO 994520D0 NO 994520 A NO994520 A NO 994520A NO 994520 A NO994520 A NO 994520A NO 994520 D0 NO994520 D0 NO 994520D0
Authority
NO
Norway
Prior art keywords
zinc
free insulin
insulin crystals
pulmonary preparations
crystals
Prior art date
Application number
NO994520A
Other languages
English (en)
Other versions
NO994520L (no
Inventor
Svend Havelund
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO994520D0 publication Critical patent/NO994520D0/no
Publication of NO994520L publication Critical patent/NO994520L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO994520A 1997-03-20 1999-09-17 Sinkfrie insulinkrystaller for anvendelse i pulmonale preparater NO994520L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK31797 1997-03-20
PCT/DK1998/000109 WO1998042749A1 (en) 1997-03-20 1998-03-20 Zinc free insulin crystals for use in pulmonary compositions

Publications (2)

Publication Number Publication Date
NO994520D0 true NO994520D0 (no) 1999-09-17
NO994520L NO994520L (no) 1999-09-17

Family

ID=8092195

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994520A NO994520L (no) 1997-03-20 1999-09-17 Sinkfrie insulinkrystaller for anvendelse i pulmonale preparater

Country Status (17)

Country Link
US (2) US20070093411A1 (no)
EP (2) EP1005490B1 (no)
JP (1) JP3764174B2 (no)
KR (1) KR20000076419A (no)
CN (1) CN1259142A (no)
AT (1) ATE321783T1 (no)
AU (1) AU742591B2 (no)
BR (1) BR9808285A (no)
CA (1) CA2283705A1 (no)
DE (1) DE69834028T2 (no)
ES (1) ES2260832T3 (no)
HU (1) HUP0000547A3 (no)
IL (1) IL131796A0 (no)
NO (1) NO994520L (no)
PL (1) PL335777A1 (no)
RU (1) RU2198181C2 (no)
WO (1) WO1998042749A1 (no)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE397013T1 (de) 1997-09-05 2008-06-15 Altus Pharmaceuticals Inc Kohlenhydrat-vernetzte glykoproteinkristalle
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
ZA989744B (en) * 1997-10-31 2000-04-26 Lilly Co Eli Method for administering acylated insulin.
WO1999055310A1 (en) * 1998-04-27 1999-11-04 Altus Biologics Inc. Stabilized protein crystals, formulations containing them and methods of making them
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
EP1073421A1 (en) * 1998-04-27 2001-02-07 Altus Biologics Inc. Stabilized protein crystals, formulations containing them and methods of making them
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
AU4450700A (en) * 1999-04-27 2000-11-10 Eli Lilly And Company Insulin crystals for pulmonary administration
GB0011807D0 (en) * 2000-05-16 2000-07-05 Quadrant Holdings Cambridge Formulation for inhalation
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10250297A1 (de) * 2002-10-29 2004-05-19 Aventis Pharma Deutschland Gmbh Kristalle von Insulinanaloga und Verfahren zu ihrer Herstellung
US7193035B2 (en) 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
EP2107069B1 (en) * 2003-08-05 2013-01-16 Novo Nordisk A/S Novel insulin derivatives
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
AU2005209199B2 (en) 2004-01-16 2008-09-11 Biodel Inc. Sublingual drug delivery device
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
KR100798333B1 (ko) * 2005-08-03 2008-01-28 고려대학교 산학협력단 락토오스 운반체와 혼합건조된 폐 전달용 인슐린미세결정분말
PT2349324T (pt) 2008-10-17 2017-12-06 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
EP2464655B1 (en) * 2009-08-11 2017-02-15 Biocon Limited Chromatographic processes
WO2011058083A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten, ein insulin und methionin
SG10201500871TA (en) 2009-11-13 2015-04-29 Sanofi Aventis Deutschland Pharmaceutical composition comprising a glp-1 agonist and methionine
RS55378B1 (sr) 2010-08-30 2017-03-31 Sanofi Aventis Deutschland Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
HRP20151068T1 (hr) 2011-08-29 2016-01-01 Sanofi-Aventis Deutschland Gmbh Farmaceutska kombinacija za upotrebu za glikemijsku kontrolu kod pacijenata s dijabetesom tipa 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
MX375021B (es) * 2014-07-08 2025-03-06 Amphastar Pharmaceuticals Inc Insulina micronizada, análogos de insulina micronizada y métodos para fabricarlos.
TWI758239B (zh) 2014-12-12 2022-03-21 德商賽諾菲阿凡提斯德意志有限公司 甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
CN104761632A (zh) * 2015-04-14 2015-07-08 珠海联邦制药股份有限公司 一种地特胰岛素结晶的制备方法及应用
CN106117345B (zh) * 2015-05-05 2020-11-24 宜昌东阳光长江药业股份有限公司 一种制备甘精胰岛素结晶的方法
JP2018531900A (ja) 2015-08-25 2018-11-01 ノヴォ ノルディスク アー／エス 新規インスリン誘導体及びその医学的使用
JP2018531901A (ja) 2015-08-25 2018-11-01 ノヴォ ノルディスク アー／エス 新規インスリン誘導体及びその医学的使用
CN108368163A (zh) 2015-08-25 2018-08-03 诺和诺德股份有限公司 新型胰岛素衍生物及其医学用途
US10322168B2 (en) 2016-01-07 2019-06-18 Amphastar Pharmaceuticals, Inc. High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
CN106749616B (zh) * 2016-12-19 2021-09-03 华润昂德生物药业有限公司 B30位苏氨酸缺失人胰岛素晶体的制备方法
CN109957001B (zh) * 2017-12-26 2022-11-18 甘李药业股份有限公司 甘赖脯胰岛素结晶的制备方法
PL238016B1 (pl) * 2018-07-06 2021-06-28 Bioton Spolka Akcyjna Krystaliczna, bezcynkowa postać insuliny glargine i sposób jej otrzymywania
KR102427426B1 (ko) 2019-12-11 2022-08-01 노보 노르디스크 에이/에스 신규한 인슐린 유사체 및 이의 용도

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3719655A (en) * 1969-12-05 1973-03-06 Lilly Co Eli Process for the crystallization of the ammonium and alkali metal salts in insulin
DE3327928A1 (de) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten
RU2027444C1 (ru) * 1992-05-08 1995-01-27 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Способ получения инсулина
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
HU217684B (hu) * 1993-09-17 2000-03-28 Novo Nordisk A/S Acilezett inzulinszármazékok és azokat tartalmazó gyógyszerkészítmények és előállításuk
WO1995024183A1 (en) * 1994-03-07 1995-09-14 Inhale Therapeutic Systems Methods and compositions for pulmonary delivery of insulin
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
US5597893A (en) * 1994-10-31 1997-01-28 Eli Lilly And Company Preparation of stable insulin analog crystals
US5700904A (en) * 1995-06-07 1997-12-23 Eli Lilly And Company Preparation of an acylated protein powder
US5898067A (en) * 1997-02-07 1999-04-27 Novo Nordisk A/S Crystallization of proteins
US6310038B1 (en) * 1997-03-20 2001-10-30 Novo Nordisk A/S Pulmonary insulin crystals
DE10114178A1 (de) * 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität

Also Published As

Publication number Publication date
EP1005490B1 (en) 2006-03-29
WO1998042749A1 (en) 1998-10-01
KR20000076419A (ko) 2000-12-26
US20090311326A9 (en) 2009-12-17
AU6612098A (en) 1998-10-20
HUP0000547A3 (en) 2002-11-28
NO994520L (no) 1999-09-17
US20070292520A1 (en) 2007-12-20
DE69834028T2 (de) 2006-12-07
EP1627642A2 (en) 2006-02-22
EP1005490A1 (en) 2000-06-07
JP3764174B2 (ja) 2006-04-05
CN1259142A (zh) 2000-07-05
IL131796A0 (en) 2001-03-19
ES2260832T3 (es) 2006-11-01
RU2198181C2 (ru) 2003-02-10
US20070093411A1 (en) 2007-04-26
BR9808285A (pt) 2000-05-16
DE69834028D1 (de) 2006-05-18
HUP0000547A2 (hu) 2000-08-28
JP2001506272A (ja) 2001-05-15
EP1627642A3 (en) 2006-04-19
CA2283705A1 (en) 1998-10-01
AU742591B2 (en) 2002-01-10
PL335777A1 (en) 2000-05-22
ATE321783T1 (de) 2006-04-15

Similar Documents

Publication Publication Date Title
NO994520D0 (no) Sinkfrie insulinkrystaller for anvendelse i pulmonale preparater
IT8819100A0 (it) Formulazioni galeniche a cessione programmata.
AU6618186A (en) Resinate sustained release dextromethorphan composition
IT1276723B1 (it) Formulazioni di analoghi dell'insulina
GB9501040D0 (en) Dried composition
IT1229528B (it) Sali cefalosporinici e relative composizioni iniettabili, nonche' procedimento di preparazione
ZA891681B (en) Thiazolidinedione derivatives as hypoglycemic agents
EP0318084A3 (en) Benzoheterazoles
FR2639539B1 (fr) Matieres pour empreintes dentaires, a base d'alginate, pulverulentes, ayant peu tendance a voler en poussiere
SE8700137L (sv) Diuretisk komposition
AU4717089A (en) N-(3,4-Dioxy-and N-(4-oxy-3-thio-benzyl)-thioureas
FI901659A7 (fi) 3,5-dihydroksi-6,8-nonadieenihapot ja johdannaiset kolesterolia alenta vina aineina
ZA923169B (en) Therapeutic compositions based on 1,2-dithiole-3-thione derivatives
FI933719L (fi) 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
EP0347749A3 (en) Pyrazoloacridone derivatives with anti-tumoral activity
DK10190A (da) 1,1-dioxo-cephem-4-carbothiolsyrederivater
AU3726189A (en) Aminoalkylaminocarbonyl aminodiol amino acid derivatives as anti-hypertensive agents
AU2247388A (en) 2-(2,2,2-trifluoroethyl imino)-tetrahydro-1,3,5, thiadiazin- 4-ones and their preparation and use
AU3005589A (en) N-(lower alkyl)-2-(3'-ureidobenzyl)-pyrrolidines
AU5349894A (en) 2,5-dihydro-2,5-dioxo-1(H)-azepines and 2,5-dihydro-2-oxo-1(H)-azepines and the use thereof as excitatory amino acid and glycine receptor antagonists
EP0722714A3 (en) Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them
AU2857589A (en) Biocidal 4,5-dichloro-1,2-dithiol-3-one composition
AU8433898A (en) Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for increasing insulin sensitivity
AU645041B2 (en) N-(3',4'-dimethoxycinnamoyl)anthranilic acid
KR910003267U (ko) 디에이티의 리일구동장치